Methyl 4-{5-[bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2- yl}butanoate
Modify Date: 2024-01-03 10:57:12
![Methyl 4-{5-[bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2- yl}butanoate Structure](https://www.chemsrc.com/caspic/156/109882-25-9.png)
Methyl 4-{5-[bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2- yl}butanoate structure
|
Common Name | Methyl 4-{5-[bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2- yl}butanoate | ||
|---|---|---|---|---|
| CAS Number | 109882-25-9 | Molecular Weight | 372.28900 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C17H23Cl2N3O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Name | Methyl 4-{5-[bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2- yl}butanoate |
|---|---|
| Synonym | More Synonyms |
| Molecular Formula | C17H23Cl2N3O2 |
|---|---|
| Molecular Weight | 372.28900 |
| Exact Mass | 371.11700 |
| PSA | 47.36000 |
| LogP | 3.35300 |
|
~99%
Methyl 4-{5-[bi... CAS#:109882-25-9 |
| Literature: CEPHALON, INC.; CHEN, Jian; PRZYUSKI, Katrin; ROEMMELE, Renee, Caroline Patent: WO2010/42568 A1, 2010 ; Location in patent: Page/Page column 19-20 ; |
|
~91%
Methyl 4-{5-[bi... CAS#:109882-25-9 |
| Literature: CEPHALON, INC.; BAKALE, Roger, P.; BROWN, Peter, D.; CHEN, Jian; DRAGER, Anthony, S.; LABELL, Rachel, Y.; MCKEAN, Robert, E.; PATEL, Piyush, R.; ROEMMELE, Renee, C. Patent: WO2014/75035 A1, 2014 ; Location in patent: Page/Page column 15 ; |
|
~%
Methyl 4-{5-[bi... CAS#:109882-25-9 |
| Literature: Arevipharma GmbH; Schickaneder, Helmut; Schickaneder, Christian; Limmert, Michael Patent: US2013/184471 A1, 2013 ; Location in patent: Paragraph 0146; 0147; 0148; 0149; 0150 ; |
|
~%
Methyl 4-{5-[bi... CAS#:109882-25-9 |
| Literature: Chen, Jian; Przyuski, Katrin; Roemmele, Renee; Bakale, Roger P. Organic Process Research and Development, 2011 , vol. 15, # 5 p. 1063 - 1072 |
|
~%
Methyl 4-{5-[bi... CAS#:109882-25-9 |
| Literature: Chen, Jian; Przyuski, Katrin; Roemmele, Renee; Bakale, Roger P. Organic Process Research and Development, 2011 , vol. 15, # 5 p. 1063 - 1072 |
|
~%
Methyl 4-{5-[bi... CAS#:109882-25-9 |
| Literature: Chen, Jian; Przyuski, Katrin; Roemmele, Renee; Bakale, Roger P. Organic Process Research and Development, 2011 , vol. 15, # 5 p. 1063 - 1072 |
|
~%
Methyl 4-{5-[bi... CAS#:109882-25-9 |
| Literature: Chen, Jian; Przyuski, Katrin; Roemmele, Renee; Bakale, Roger P. Organic Process Research and Development, 2011 , vol. 15, # 5 p. 1063 - 1072 |
|
~%
Methyl 4-{5-[bi... CAS#:109882-25-9 |
| Literature: Werner; Letsch; Ihn Pharmazie, 1987 , vol. 42, # 4 p. 272 - 273 |
|
~%
Methyl 4-{5-[bi... CAS#:109882-25-9 |
| Literature: Werner; Letsch; Ihn Pharmazie, 1987 , vol. 42, # 4 p. 272 - 273 |
![Methyl 4-{5-[bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2 -yl}butanoate structure](https://www.chemsrc.com/caspic/101/109882-31-7.png)
![4-[(2,4-dinitrophenyl)methylcarbamoyl]butyric acid methyl ester structure](https://www.chemsrc.com/caspic/191/1221157-10-3.png)
| Precursor 10 | |
|---|---|
| DownStream 1 | |
| Methylhydroxy-Celecoxib |
| PRIMARY ALCOHOL METABOLITE OF CELECOXIB |
| bendamustine methyl ester |
| 4'-Hydroxycelecoxib |
| Hydroxy Celecoxib |
| Celecoxib metabolite M3 |